Swiss Life Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Swiss Life Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.28M	Buy	126,338 +24,348	+24%	+$811K	0.02%	486
2026 Q1	$3.07M	Buy	101,990 +5,497	+6%	+$177K	0.02%	493
2025 Q4	$3.01M	Sell	96,493 -38,849	-29%	-$957K	0.02%	498
2025 Q3	$2.73M	Sell	135,342 -5,047	-4%	-$88.6K	0.01%	515
2025 Q2	$2.35M	Buy	140,389 +47,738	+52%	+$770K	0.01%	531
2025 Q1	$1.42M	Buy	92,651 +16,532	+22%	+$295K	0.01%	561
2024 Q4	$1.68M	Buy	+76,119	New	+$1.38M	0.01%	503
2017 Q2	–	Sell	-19,905	Closed	-$639K	–	480
2017 Q1	$639K	Buy	+19,905	New	+$679K	0.02%	366
2016 Q2	–	Sell	-3,979	Closed	-$213K	–	378
2016 Q1	$213K	Sell	3,979 -155	-4%	-$9.1K	0.01%	342
2015 Q4	$271K	Buy	+4,134	New	+$255K	0.01%	286

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Swiss Life Asset Management's TEVA Position: Q2 2026 in Review

Swiss Life Asset Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 24% in Q2 2026, buying an estimated $811K and bringing the position to 126,338 shares worth $4.28M. The position accounts for 0.02% of the portfolio, ranked #486.

Swiss Life Asset Management first reported a position in TEVA in Q4 2015 and has held it in 10 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Swiss Life Asset Management held 126,338 shares of Teva Pharmaceutical Industries Limited worth $4.28M as of Q2 2026.
Swiss Life Asset Management bought 24,348 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $811K.
Teva Pharmaceutical Industries Limited made up 0.02% of Swiss Life Asset Management's portfolio in Q2 2026, its #486 holding.
Swiss Life Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and has held it in 10 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.